BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6381791)

  • 1. [A case of aplastic anemia treated by allogeneic bone marrow transplantation using immunoadsorbent for major ABO incompatibility].
    Shinohara K; Yamada K; Fujii Y; Inoue M; Yoshizaki Y; Sadato T; Kaneko T; Matsumoto N; Hiroshige Y; Juji J
    Rinsho Ketsueki; 1984 Apr; 25(4):583-7. PubMed ID: 6381791
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe aplastic anemia treated by allogeneic bone marrow transplantation, using immunoadsorbent for major ABO incompatibility].
    Toyoda Y; Tonouchi T; Mimaya J; Yamamoto M; Sakata K; Nakao J
    Rinsho Ketsueki; 1985 Jul; 26(7):1135-9. PubMed ID: 3903258
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of cryofiltration in major ABO-incompatible bone marrow transplantation.
    Kasai M; Imai K; Kobayashi N; Kawamura K; Meguro J; Kukita K; Yonekawa M; Kawamura A; Hashino S; Fukuhara T
    Transplant Proc; 1987 Dec; 19(6):4629-31. PubMed ID: 3321635
    [No Abstract]   [Full Text] [Related]  

  • 4. [ABO incompatibility in allogeneic bone marrow transplantation].
    Quabeck K; Beelen DW; Mahmoud HK; Schaefer UW; Schmidt CG; Henneberg-Quester KB; Luboldt W
    Beitr Infusionther Klin Ernahr; 1987; 18():310-5. PubMed ID: 3326589
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma exchange for bone marrow transplantation.
    Ho W
    Prog Clin Biol Res; 1982; 88():287-94. PubMed ID: 7048328
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility.
    Curtis JE; Messner HA
    Can Med Assoc J; 1982 Mar; 126(6):649-55. PubMed ID: 7039802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow transplantation in Seattle. Improved treatment in aplastic anemia and acute leukemia].
    Ringdén O
    Lakartidningen; 1979 Dec; 76(50):4588-92. PubMed ID: 43441
    [No Abstract]   [Full Text] [Related]  

  • 8. [ABO-incompatible allogeneic bone marrow transplantation].
    Xu L; Guo N; Wang S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstacle to red cell engraftment due to major ABO incompatibility in allogeneic bone marrow transplants (BMT): quantitative and kinetic aspects in 58 BMTs.
    Reviron J; Schenmetzler C; Bussel A; Frappaz D; Devergie A; Gluckman E
    Transplant Proc; 1987 Dec; 19(6):4618-22. PubMed ID: 3321633
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of techniques for dealing with major ABO-incompatible marrow transplants.
    Bensinger WI; Buckner CD; Clift RA; Williams BM; Banaji M; Thomas ED
    Transplant Proc; 1987 Dec; 19(6):4605-8. PubMed ID: 3321630
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
    Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
    Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohematologic problems arising from ABO incompatible bone marrow transplantation.
    Sniecinski IJ; Petz LD; Oien L; Blume KG
    Transplant Proc; 1987 Dec; 19(6):4609-11. PubMed ID: 3321631
    [No Abstract]   [Full Text] [Related]  

  • 13. [Allogeneic bone marrow transplantation from ABO incompatible donor].
    Harada M; Nakao S; Ueda M; Kondo K; Odaka K; Ohtake S; Shiobara S; Matsue K; Mori T; Yoshida T
    Rinsho Ketsueki; 1984 Jan; 25(1):45-51. PubMed ID: 6379225
    [No Abstract]   [Full Text] [Related]  

  • 14. [Administration of haptoglobin in ABO incompatible bone marrow transplantation].
    Ito M; Imoto S; Nakagawa T; Kai S; Hara H
    Rinsho Ketsueki; 1990 Oct; 31(10):1716-20. PubMed ID: 2255063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation across the ABO barrier.
    Biggs JC; Concannon AJ; Dodds AJ; Isbister JP; Kesteven P
    Med J Aust; 1979 Aug; 2(4):173-5. PubMed ID: 390333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
    Maschan AA; Skorobogatova EV; Balashov DN; Pashanov ED; Trakhtman PE; Schipitzina IP; Skvortsova YV; Rumiantzev AG
    Bone Marrow Transplant; 2002 Sep; 30(6):405-7. PubMed ID: 12235527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma-exchange and in vivo immunoabsorption of isohemagglutinins in bone marrow transplantation across major ABO barrier.
    Iacone A; D'Arcangelo L; Di Bartolomeo P; Di Girolamo G; Dragani A; Torlontano G
    Haematologica; 1982; 67(6):874-84. PubMed ID: 6819193
    [No Abstract]   [Full Text] [Related]  

  • 19. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO-incompatible bone marrow transplantation: in vivo adsorption, an old forgotten method.
    Tichelli A; Gratwohl A; Wenger R; Osterwalder B; Nissen C; Burri HP; Speck B
    Transplant Proc; 1987 Dec; 19(6):4632-7. PubMed ID: 3321636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.